Sanjay Marasini

Dr. Sanjay Marasini

New Zealand - National Eye Centre, Department of Ophthalmology, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
SMSanjay Marasini
Sanjay Marasini
LLLeon G. Leanse
Leon G. Leanse
TDTianhong Dai
Tianhong Dai

1 February 2012 in Optometry and Vision Science
Verified
Journal Article
Closed access
RSRanjana Sharma
Ranjana Sharma
SMSanjay Marasini
Sanjay Marasini
ASAnanda Kumar Sharma
Ananda Kumar Sharma
JSJeevan Kumar Shrestha
Jeevan Kumar Shrestha
BNBhagvat Prasad Nepal
Bhagvat Prasad Nepal

1 January 2014 in Clinical and Experimental Optometry
Verified
Journal Article
Closed access
PDF file
RGRajendra Gyawali
Rajendra Gyawali
FMFathimath Nestha Mohamed
Fathimath Nestha Mohamed
JBJeewanand Bist
Jeewanand Bist
Himal KandelHimal Kandel
Himal Kandel
SMSanjay Marasini
Sanjay Marasini
JKJyoti Khadka
Jyoti Khadka

1 October 2020 in The Ocular Surface
Verified
Journal Article
Closed access
AMAlex Muntz
Alex Muntz
SMSanjay Marasini
Sanjay Marasini
MWMichael T.M. Wang
Michael T.M. Wang
Jennifer P CraigJennifer P Craig
Jennifer P Craig

1 April 2021 in The Ocular Surface
Verified
Journal Article
Closed access
SMSanjay Marasini
Sanjay Marasini
OMOdunayo O. Mugisho
Odunayo O. Mugisho
Simon SwiftSimon Swift
Simon Swift
HRHannah Read
Hannah Read
IRIlva D. Rupenthal
Ilva D. Rupenthal
Jennifer P CraigJennifer P Craig
Jennifer P Craig

12 September 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
LLLeon Gerald Leanse
Leon Gerald Leanse
SMSanjay Marasini
Sanjay Marasini
CACarolina Dos Anjos
Carolina Dos Anjos
Tianhong DaiTianhong Dai
Tianhong Dai
In recent years, with the increases in microorganisms that express a multitude of antimicrobial resistance (AMR) mechanisms, the threat of antimicrobial resistance in the global population has reached critical levels. The introduction of the COVID-19 pandemic has further contributed to the influx of infections caused by multidrug-resistant organisms (MDROs), which has placed significant pressure on healthcare systems. For over a century, the potential for light-based approaches targeted at combatting both cancer and infectious diseases has been proposed. They offer effective killing of microbial pathogens, regardless of AMR status, and have not typically been associated with high propensities of resistance development. To that end, the goal of this review is to describe the different mechanisms that drive AMR, including intrinsic, phenotypic, and acquired resistance mechanisms. Additionally, the different light-based approaches, including antimicrobial photodynamic therapy (aPDT), antimicrobial blue light (aBL), and ultraviolet (UV) light, will be discussed as potential alternatives or adjunct therapies with conventional antimicrobials. Lastly, we will evaluate the feasibility and requirements associated with integration of light-based approaches into the clinical pipeline.